CLASS II ONGOING Device recall · Reported 23 Mar 2022 · FDA Enforcement Report

BioPlex 2200 REF 12000651 Syphilis Total & RPR Calibrator Set CAL recalled

Bio-Rad Laboratories is recalling BioPlex 2200 REF 12000651 Syphilis Total & RPR Calibrator Set CAL, distributed nationwide in the US. The recall was initiated on 8 Feb 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog Number: 12000651 UDI GTIN Code: 03610520652770 Lot Numbers: 53262
Quantity recalled724 Calibrator sets (U.S.)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0807-2022
FDA event ID
89684
Recalling firm
Bio-Rad Laboratories, Redmond, WA
Classification
Class II
Status
Ongoing
Recall initiated
8 Feb 2022
FDA classified
16 Mar 2022
Reported
23 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

8 Feb 2022Recall initiated by company
16 Mar 2022Classified by FDA+36 days
23 Mar 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to current concerns related to COVID-19 vaccine interference with the RPR portion of the BioPlex 2200 Syphilis Total & RPR panel, as well as intermittent manufacturing challenges to produce RPR reagents that consistently meet stability specifications

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

BioPlex 2200 REF 12000651 Syphilis Total & RPR Calibrator Set CAL

Where it was distributed

Worldwide distribution U.S. Nationwide distribution in the states of AK, AL, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WV. The countries of France, Germany, Italy, Spain, Saudi Arabia, and United Arab Emirates.

Nationwide AlaskaAlabamaArizonaCaliforniaColoradoConnecticutFloridaGeorgiaHawaiiIowaIllinoisIndianaKansasKentuckyLouisianaMassachusettsMaineMichiganMinnesotaMissouri

Questions about this recall

Why was it recalled?

Due to current concerns related to COVID-19 vaccine interference with the RPR portion of the BioPlex 2200 Syphilis Total & RPR panel, as well as intermittent manufacturing challenges to produce RPR reagents that consistently meet stability specifications

Which lots are affected?

Catalog Number: 12000651 UDI GTIN Code: 03610520652770 Lot Numbers: 53262

Where was it sold?

Worldwide distribution U.S. Nationwide distribution in the states of AK, AL, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WV. The countries of France, Germany, Italy, Spain, Saudi Arabia, and United Arab Emirates.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 89684

This product is part of a recall event; the main page for the event is BioPlex 2200 REF 12000650 Syph T Pack Syphilis Total & RPR Reagent recalled.

More recalls from Bio-Rad Laboratories

All 27

Other Other Medical Devices recalls

All 13,884